We would like to say a big thank you to all participants for taking part in MIND, MOOD & MICROBES – the 1st International Conference on Microbiota-Gut-Brain Axis – and making it the success that it was.
Bridging the gap between animal studies and application for treatment in humans will be the next big challenge. There are still many mysteries when it comes to understanding how the microbiome might affect the brain. If research is able to solve even a fraction of them, the microbiota-brain axis could be a powerful target for influencing mood and behaviour, for example in anxiety and depression, as well as preventing or treating brain-related diseases, including (potentially) Parkinson’s disease, Alzheimer’s disease, schizophrenia and autism.
MIND, MOOD & MICROBES – the 1st International Conference on Microbiota-Gut-Brain Axis – was focused on breakthroughs in fundamental research and dissemination of fundamental research towards clinical applications. The conference, designed for academia, health professionals and health-related industries, was accredited by the Netherlands Association of Psychiatrist (NVvP) (11 points).